Lupin Ltd

Lupin | 500257

Market Closed

₹2,052.10

+₹0.00 (+-0.16%)

As on 18/11/25, 9:32 PM

Market Cap93,878.33 CR

Current Price₹2,052.1

High / Low₹2,402.9 / 1,795.2

PE Ratio28.2

Book Value₹376.77

Dividend Yield0.59%

ROCE20.88%

ROE17.70%

Face Value₹2.00

Current Vol.9,89,649

Average Vol.12,76,53,456

ISININE326A01037

PB Ratio5.38

Debt to Equity0.27

Net Profit Margin14.56

Operating Margin24.13

Stock cgart

Stock Performance

₹2,480₹2,490

₹2,500

Previous CloseToday's Open

₹1,800₹3,000

₹2,500

52W Low52W High

₹2,480Today's Open

₹2,490Previous Close

12,00,000Volume

₹1,80052W Low

₹3,00052W High

Ratios

No data available

About Company

Lupin is an innovation led Transnational Pharmaceutical Company producing, developing and marketing a wide range of branded & generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally
The Company has significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, Central Nervous System (CNS), Gastro-Intestinal (GI), Anti-Infective and Nonsteroidal Anti Inflammatory Drug (NSAID) therapy segments and is a global leader in the Anti-TB and Cephalosporins segments
Lupin Limited was incorporated in the year 1983 with the name Lupin Chemicals Limited
In March 2001, Lupin Laboratories Limited was amalgamated with the company and the name was changed to Lupin Limited
In the year 1987, the company commenced operations in Cephalexin Plant at Mandideep and 7 ADCA plant at Ankleshwar
In the year 1989, the company established a joint venture in Thailand, namely Lupin Chemicals (Thailand) Ltd
In the year 1991, they initiated production of Injectable cephalosporin (bulk and dosages) at Mandideep
In the year 1992, the company set up Fermentation Plant at Tarapur, Maharashtra
Also, Sterile Plant for injectable Cephalosporins (bulk) was commissioned at Mandideep
They commenced supply of Cephalosporin bulk actives to their alliance partners in the US

Research Calls

Explore all active research calls & maximize your profits

To access, login or signup with ArihantPlus

;

Technical Indicators

RSI64.79

SMA 201973.62

SMA 501973.46

SMA 1001954.11

SMA 2001985.08

SMA 102006.84

MACD_12_26_Days23.18

EMA10Day2013.32

EMA20Day1990.30

EMA50Day1972.03

MACD_12_26_9_Days11.62

EMA100Day1972.09

EMA200Day1970.90

Pivot Points

Volume Analysis

Growth Rate

Revenue Growth13.48%

ROE21.00%

EBITDA Margin24.13%

All figures in ₹ Crores

Indicators	2025	2024	2023	2022	2021
Revenue	22,707.90	20,010.82	16,641.66	16,405.48	15,162.96
Interest	294.87	311.61	274.30	142.77	140.64
Expenses	17,430.38	16,210.81	14,921.09	16,186.66	12,596.08
Financing Profit	5,479.13	3,930.69	1,871.48	429.27	2,704.50
Financing Margin %	24%	20%	11%	3%	18%
Other Income	201.61	130.68	150.91	210.45	137.62
Depreciation	1,169.26	1,196.81	880.69	1,658.71	887.41
Profit before tax	4,015.00	2,422.27	716.49	-1,372.21	1,676.45
Tax %	18%	20%	38%	-10%	27%
Net Profit	3,306.26	1,935.57	447.69	-1,509.36	1,227.93
EPS in Rs	71.95	42.05	9.46	-33.65	26.84

Show % Change

ShareHolding

📊

No Information Available

No shareholding data available at this time.

Deal	Date	Type	Quantity	Price	Traded %
GOLDMAN SACHS BANK EUROPE SE - ODI	14 Oct ‘25	Purchase	60,035	₹1,937.5	7.99%
GOLDMAN SACHS (SINGAPORE) PTE - ODI	14 Oct ‘25	Sell	60,035	₹1,937.5	7.99%
GOLDMAN SACHS BANK EUROPE SE - ODI	13 Oct ‘25	Purchase	81,892	₹1,977	15.43%
GOLDMAN SACHS (SINGAPORE) PTE - ODI	13 Oct ‘25	Sell	81,892	₹1,977	15.43%
ISHARES CORE MSCI EMERGING MARKETS ETF	14 Nov ‘22	Purchase	2,28,477	₹747	13.89%
ISHARES CORE EMERGING MARKETS MAURITIUS CO	14 Nov ‘22	Sell	2,28,477	₹747	13.89%
ISHARES CORE MSCI EMERGING MARKETS ETF	03 Nov ‘22	Purchase	2,28,477	₹707.45	45.50%
ISHARES CORE EMERGING MARKETS MAURITIUS CO	03 Nov ‘22	Sell	2,28,477	₹707.45	45.50%
ISHARES CORE EMERGING MARKETS MAURITIUS CO	03 Oct ‘22	Sell	2,45,648	₹679.85	3.71%
ISHARES CORE MSCI EMERGING MARKETS ETF	03 Oct ‘22	Purchase	2,45,648	₹679.85	3.71%

News

17 Nov 2025 12:00 am

USFDA completes specific Pre Approval Inspection of Lupin's Unit 1 in Nagpur

17 Nov 2025 12:00 am

Lupin’s Nagpur unit clears USFDA pre-approval inspection with no observations

14 Nov 2025 12:00 am

Lupin launches Risperidone for extended-release injectable suspension

12 Nov 2025 12:00 am

Lupin Manufacturing Solutions inaugurates dedicated Oncology Block at its Vizag facility

Record Date

Corporate Action

Information

Announcement Day

11 Aug 2025

AGM

14 Jul 2025

25 Jul 2025

Final Dividend (₹12)

Outcome of Board Meeting - Audited Financial Results for the quarter and year ended March 31, 2025 and recommendation of Dividend Recommended a Dividend of 12/- (Rupees Twelve only) per Equity Share (i.e. 600%) of the face value of 2/- (Rupees Two only) each fully paid up, for the financial year ended March 31, 2025, subject to approval of the Members at the ensuing Annual General Meeting (AGM'). The Dividend shall be paid within 30 days from the date of approval by the Members at the ensuing AGM. Intimation of the Forty-Third Annual General Meeting of the Company and Record Date for payment of Dividend. (As Per BSE Announcement Dated on :14.07.2025)

14 May 2025

02 Aug 2024

AGM

09 Jul 2024

16 Jul 2024

Final Dividend (₹8)

Approval Of The Audited Financial Statements For The Quarter And Year Ended March 31, 2024 And Recommend Final Dividend @ 400% i.e. Rs. 8/- Per Equity Share Of The Face Value of Rs. 2/- Each For The Year Ended March 31, 2024. Lupin Limited has fixed Tuesday, July 16, 2024, as the ''Record Date'' for the purpose of ascertaining the Shareholders who will be entitled to payment of dividend, if declared at the Annual General Meeting (As per BSE Announcement Dated on 04/07/2024)

06 May 2024

03 Aug 2023

AGM

04 Jul 2023

14 Jul 2023

Final Dividend (₹4)

Audited Financial Statements for the quarter and year ended March 31, 2023. Regulation 30(2) read with Schedule Ill Part A Para A (4) (a) of the Listing Regulations, recommended dividend @ 2003 i.e. 4/- per equity share of the face value of 2 each for the year ended March 31, 2023, subject to approval of Members at the ensuing Annual General Meeting. The total outflow would be 1820.1 million The Company has fixed Friday, July 14, 2023, as the ''Record Date'' for the purpose of ascertaining the shareholders who will be entitled to payment of Dividend. (As Per BSE Announcement dated on 04.07.2023)

09 May 2023

03 Aug 2022

AGM

05 Jul 2022

15 Jul 2022

Final Dividend (₹4)

Lupin Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 18, 2022, inter alia, has recommended dividend @200% i.e.Rs. 4/- per equity share of the face value of Rs. 2/- each for the year ended March 31, 2022, subject to approval of Members at the ensuing Annual General Meeting. The total outflow would be Rs. 1818 million.

19 May 2022

11 Aug 2021

AGM

15 Jul 2021

28 Jul 2021

Final Dividend (₹6.5)

Lupin Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 12, 2021, inter alia, has recommended dividend @ 325% i.e. Rs. 6.50 per equity share of the face value of Rs. 2/- each for the year ended March 31, 2021, subject to approval of Members at the ensuing Annual General Meeting. The total outflow would be Rs. 2949.2 mn.

13 May 2021

Peers

LTP(₹)	Market Cap(₹ Cr.)	P/E Ratio(Ratio)	P/B Ratio(Ratio)	Cash Earnings(Ratio)	Debt to Equity(Ratio)	Net Profit Ratio(%)
2,047	93,506	22	5	17	0	14.56%
1,760	4,22,211	37	5	30	0	20.88%
6,475	1,71,898	69	11	59	0	23.41%
3,793	1,28,372	59	15	43	1	16.60%
1,515	1,22,349	22	4	19	0	19.21%
1,244	1,03,789	18	3	14	0	17.54%
928	93,404	19	4	15	0	19.86%
2,224	91,800	53	6	35	0	14.39%
1,240	72,630	21	2	14	0	10.98%
5,711	68,288	29	5	25	0	17.09%

Showing 10 of 124 Results

#IndiaInvests

Trusted by 2.5 lac + Indians for their wealth-building needs

Invest in stocks with ease

Open your account in less than 10 mins*

By proceeding, you agree to all T&C *

Top Gainers

Top Losers

Frequently Asked Questions

What is Share Price of Lupin Ltd?

The current share price of Lupin Ltd (Lupin) is ₹2052.10. This price reflects the latest market valuation and is updated in real-time during trading hours.

What is the P/E Ratio of Lupin Ltd?

The Price-to-Earnings (P/E) ratio of Lupin Ltd is 2052.10. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.

What is the 52-week high and low of Lupin Ltd?

Lupin Ltd has a 52-week high of ₹2402.90 and a 52-week low of ₹1795.20. This range shows the stock's price volatility over the past year.

What is the Dividend Yield of Lupin Ltd?

Lupin Ltd offers a dividend yield of 0.58%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.

What is the EPS of Lupin Ltd?

The Earnings Per Share (EPS) of Lupin Ltd is ₹94.68. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.

What is the ROE of Lupin Ltd?

Lupin Ltd has a Return on Equity (ROE) of 17.70%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.

Disclaimer:

Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.

Ready to invest smarter?
Download the app today.

GET IT ON

Google Play

4.5

DOWNLOAD ON THE

App Store

4.2

Discover our app's power in seconds.